Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEK RXFP2 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., J. Pharmacol. Exp. Ther., Jan 2007; 320: 281 - 290 | Link | |||
HEK RXFP2 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., Mol. Pharmacol., Jul 2006; 70: 214 - 226. | Link | |||
HEK-sGC |
Human embryonic kidney cell line, stably expressing human sGC (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S. Meurer et al., Circ. Res., Jul 2009; 105: 33 - 41 | Link | |||
HEK-TetOn |
Human embryonic kidney cell line stably, expressing the tetracycline transactivators (TetON) | Human | urinary system | cell line | adherent | Metafectene | publication | L. Zhuang et al., Archives of Biochemistry and Biophysics, 2017, 625-626: 54-64, http://dx.doi.org/10.1016/j.abb.2017.06.002 | |||||
HEK-TetOn |
Human embryonic kidney cell line stably, expressing the tetracycline transactivators (TetON) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | F. Steinberg et al., J. Biol. Chem., Nov 2010; 285: 37704 - 37715 | Link | |||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | D. A. Eisinger et al., J. Biol. Chem., Dec 2009; 284: 34819 - 34828 | Link | |||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | |||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. A. Eisinger et al., J. Biol. Chem., Dec 2009; 284: 34819 - 34828 | Link | ||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | L. Hoa et al., Cellular Signalling, 2016, 28: 488-497; doi.org/10.1016/j.cellsig.2016.02.012 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | X. Lin et al., PLoS Pathog, 2015, 11(12): e1005344. doi:10.1371/journal.ppat.1005344 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | A. Schinzel et al., J. Cell Biol., Mar 2004; 164: 1021 - 1032 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | S. Pankiv et al., J. Cell Biol., Jan 2010; 188: 253 - 269 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. Seo et al., PNAS, Aug 2015; 112: E4246 - E4255 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | H. C. Kim et al., SLAS Discovery, 2017, 22 (8): 1053 -1059, doi.org/10.1177/2472555217699823 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S. Tinschert et al., Nephrol. Dial. Transplant., Dec 2004; 19: 3150 - 3154 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. Kaiser et al., Cell. and Mol. Life Sciences, 2019, doi.org/10.1007/s00018-019-03432-7 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | K. Raafat et al., Toxicol. Sci., Nov 2010; 118: 171 - 182 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | J. Kovalcıkova et al., FASEB J., 2019, 33: 14103–14117, doi: 10.1096/fj.201900685RR | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | C. Moreno et al., Cardiovasc. Res, Sep 2015; 107: 613 - 623 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | A. Trefier et al., The FASEB Journal, October 2017, article fj.201700763R, DOI: 10.1096/fj.201700763R | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | J. C. Mercer et al., J. Biol. Chem., Aug 2006; 281: 24979 - 24990 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | A. I. Mendes et al., Mol. Cell. Biol., Oct 2011; 31: 4076 - 4086 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene | publication | A. de Araujo Brasil et al., PNAS, 2019, 116, 51: 25991–26000, doi/10.1073/pnas.1902483116 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S. Hontelez et al., J. Immunol., Apr 2013; 190: 3172 - 3179 | Link |